Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Acute Kidney Injury | Research

Multiple blood gas variables predict AKI survival in an independent manner

Authors: Rebecca Lehmann, Oliver Ritter, Johanna Tennigkeit, Susann Patschan, Daniel Patschan

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background and aim

Acute kidney injury (AKI) is becoming increasingly prevalent among hospitalized patients and carries a poor prognosis. While new biomarkers show promise in identifying early stages of AKI, accurately predicting severe outcomes such as the need for kidney replacement therapy (KRT) or death remains a challenge. However, blood gas analyses (BGA) can be used to diagnose life-threatening complications associated with AKI. The objective of this study was to assess the role of BGA as a biomarker panel in both emerging and established cases of AKI.

Methods

Retrospective observational study examining subjects with newly developed acute kidney injury (AKI). The study will document venous and arterial pH, pCO2, and actual bicarbonate levels upon hospital admission and at the onset of AKI. The primary endpoints include in-hospital mortality, the need for kidney replacement therapy (KRT), and the recovery of kidney function (ROKF).

Results

A total of 202 individuals were included in the study. Three variables were found to be independent predictors of in-hospital survival: admission arterial pH, arterial pH at acute kidney injury (AKI) onset, and arterial pCO2 at AKI onset. Additionally, venous pCO2 at AKI onset was identified as an independent predictor for the need of kidney replacement therapy (KRT).

Conclusions

Our study suggests that blood gas analysis may have a potential role in predicting severe outcome variables in acute kidney injury (AKI). The associated costs are minimal.
Literature
1.
2.
go back to reference Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. 2012.CrossRef Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. 2012.CrossRef
3.
go back to reference Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, et al. Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement. JAMA Netw Open. 2020;3: e2019209.CrossRefPubMed Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, et al. Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement. JAMA Netw Open. 2020;3: e2019209.CrossRefPubMed
4.
go back to reference Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J. Acute kidney injury. Nat Rev Dis Primer. 2021;7:52.CrossRef Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J. Acute kidney injury. Nat Rev Dis Primer. 2021;7:52.CrossRef
5.
go back to reference Hu J, Wang Y, Geng X, Chen R, Xu X, Zhang X, et al. Metabolic acidosis as a risk factor for the development of acute kidney injury and hospital mortality. Exp Ther Med. 2017;13:2362–74.CrossRefPubMedPubMedCentral Hu J, Wang Y, Geng X, Chen R, Xu X, Zhang X, et al. Metabolic acidosis as a risk factor for the development of acute kidney injury and hospital mortality. Exp Ther Med. 2017;13:2362–74.CrossRefPubMedPubMedCentral
6.
go back to reference Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol. 2012;59:246–55.CrossRefPubMedPubMedCentral Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol. 2012;59:246–55.CrossRefPubMedPubMedCentral
7.
go back to reference Gisewhite S, Stewart IJ, Beilman G, Lusczek E. Urinary metabolites predict mortality or need for renal replacement therapy after combat injury. Crit Care Lond Engl. 2021;25:119.CrossRef Gisewhite S, Stewart IJ, Beilman G, Lusczek E. Urinary metabolites predict mortality or need for renal replacement therapy after combat injury. Crit Care Lond Engl. 2021;25:119.CrossRef
8.
go back to reference Stewart IJ, Glass KR, Howard JT, Morrow BD, Sosnov JA, Siew ED, et al. The potential utility of urinary biomarkers for risk prediction in combat casualties: a prospective observational cohort study. Crit Care Lond Engl. 2015;19:252.CrossRef Stewart IJ, Glass KR, Howard JT, Morrow BD, Sosnov JA, Siew ED, et al. The potential utility of urinary biomarkers for risk prediction in combat casualties: a prospective observational cohort study. Crit Care Lond Engl. 2015;19:252.CrossRef
10.
go back to reference Marx D, Metzger J, Pejchinovski M, Gil RB, Frantzi M, Latosinska A, et al. Proteomics and Metabolomics for AKI Diagnosis. Semin Nephrol. 2018;38:63–87.CrossRefPubMed Marx D, Metzger J, Pejchinovski M, Gil RB, Frantzi M, Latosinska A, et al. Proteomics and Metabolomics for AKI Diagnosis. Semin Nephrol. 2018;38:63–87.CrossRefPubMed
11.
go back to reference Hoste E, Bihorac A, Al-Khafaji A, Ortega LM, Ostermann M, Haase M, et al. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study. Intensive Care Med. 2020;46:943–53.CrossRefPubMedPubMedCentral Hoste E, Bihorac A, Al-Khafaji A, Ortega LM, Ostermann M, Haase M, et al. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study. Intensive Care Med. 2020;46:943–53.CrossRefPubMedPubMedCentral
12.
go back to reference Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008;1:200–8.CrossRefPubMedPubMedCentral Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008;1:200–8.CrossRefPubMedPubMedCentral
13.
go back to reference Hollinger A, Wittebole X, François B, Pickkers P, Antonelli M, Gayat E, et al. Proenkephalin A 119–159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study. Kidney Int Rep. 2018;3:1424–33.CrossRefPubMedPubMedCentral Hollinger A, Wittebole X, François B, Pickkers P, Antonelli M, Gayat E, et al. Proenkephalin A 119–159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study. Kidney Int Rep. 2018;3:1424–33.CrossRefPubMedPubMedCentral
14.
go back to reference de Somer F, Mulholland JW, Bryan MR, Aloisio T, Van Nooten GJ, Ranucci M. O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management? Crit Care Lond Engl. 2011;15:R192.CrossRef de Somer F, Mulholland JW, Bryan MR, Aloisio T, Van Nooten GJ, Ranucci M. O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management? Crit Care Lond Engl. 2011;15:R192.CrossRef
15.
go back to reference Ali S, Badi S, Yousef B. Physicians’ knowledge and practice with regard to acute kidney injury at Omdurman Military Hospital: A cross-sectional survey. Int J Health Allied Sci. 2020;9:39.CrossRef Ali S, Badi S, Yousef B. Physicians’ knowledge and practice with regard to acute kidney injury at Omdurman Military Hospital: A cross-sectional survey. Int J Health Allied Sci. 2020;9:39.CrossRef
16.
go back to reference Adejumo O, Akinbodewa A, Alli O, Olufemi P, Olatunji A. Assessment of Knowledge of Acute Kidney Injury among Non-Nephrology Doctors in Two Government Hospitals in Ondo City, Southwest. Nigeria Ethiop J Health Sci. 2017;27:147–54.CrossRefPubMed Adejumo O, Akinbodewa A, Alli O, Olufemi P, Olatunji A. Assessment of Knowledge of Acute Kidney Injury among Non-Nephrology Doctors in Two Government Hospitals in Ondo City, Southwest. Nigeria Ethiop J Health Sci. 2017;27:147–54.CrossRefPubMed
Metadata
Title
Multiple blood gas variables predict AKI survival in an independent manner
Authors
Rebecca Lehmann
Oliver Ritter
Johanna Tennigkeit
Susann Patschan
Daniel Patschan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03470-9

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.